Report on antipsychotic effectiveness of moban at 800 mg. a day P.O
Camp, E.W.
Diseases of the Nervous System 38(11): 956
1977
ISSN/ISBN: 0012-3714 PMID: 913232 Document Number: 116499
Document emailed within 1 workday
Related Documents
Klushnik, T.P.; Syriachenko, T.M.; Brusov, O.S.; Sarmanova, Z.V.; Otman, I.N.; Dupin, A.M.; Sokolov, R.E. 2008: Serum immunological markers as predictors of effectiveness of antipsychotic therapy in patients with schizophrenia Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 108(1): 31-35Thomas, J.; McEvoy, J.P.; Miller, B.J. 2019: Urinary tract infection, inflammation, and cognition in phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness Study Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 31(4): 242-248
Diurni, M.; Baranzini, F.; Costantini, C.; Poloni, N.; Vender, S.; Callegari, C. 2009: Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study Recenti Progressi in Medicina 100(2): 103
Lin, S-Ku.; Chen, C-Ken. 2006: Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report Journal of Clinical Psychiatry 67(8): 1307
Dufresne, R.L.; Wagner, R.L. 1988: Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia Journal of Clinical Psychiatry 49(11): 435-438
Camp, E.W. 1977: Tardive dyskinesia oral facial dyskinesia with moban Diseases of the Nervous System 38(9): 759
Splett, P.L. 1991: Phase I: status report of existing data on the effectiveness, cost, and cost effectiveness of nutrition care services Journal of the American Dietetic Association Suppl: S9-14
Splett, P.L. 1991: Phase I: status report of existing data on the effectiveness, cost, and cost effectiveness of nutrition care services Journal of the American Dietetic Association Suppl: S9-14
Conte, D.; Mandelli, C.; Cesana, M.; Ferrini, R.; Marconi, M.; Bianchi, A. 1989: Effectiveness of erythrocytapheresis in idiopathic hemochromatosis. Report of 14 cases International Journal of Artificial Organs 12(1): 59-62
2003: Choice of an antipsychotic Medical Letter on Drugs and Therapeutics 45(1172): 102-104
Behne, D.; Clark, F.; Jennings, M.; Pallais, V.; Olson, H.; Wolf, L.; Tyler, E.T. 1956: Clinical effectiveness of a new vaginal contraceptive cream; a preliminary report Western Journal of Surgery Obstetrics and Gynecology 64(3): 152-157
Christie, G.A. 1969: Chlormadinone acetate 0-5 mg. A report on its effectiveness in continuous use as an oral contraceptive Medical Journal of Australia 2(4): 185-189
Carruthers, J.; Carruthers, A. 2009: Two-center Canadian report on the safety and effectiveness of Evolence Breeze Journal of Drugs in Dermatology: Jdd 8(9): 830-834
Marks, R.C.; Luchins, D.J. 1991: Antipsychotic medications and seizures Psychiatric Medicine 9(1): 37-52
Bourin, M. 2006: Pharmacology of antipsychotic drugs L'Encephale 32 Pt 2: S8-S9
Plesnicar, B.K.; Dolzan, V.; Zalar, B. 2008: CYP 2D6 polymorphism and antipsychotic therapy Psychiatria Danubina 20(3): 369-371
Raskind, M.A.; Risse, S.C. 1986: Antipsychotic drugs and the elderly Journal of Clinical Psychiatry 47 Suppl: 17-22
Vieta, E. 2004: Antipsychotic drugs and pregnancy Medicina clinica 123(13): 517-8; author reply 518
Dresse, A. 1996: Neuroleptics or antipsychotic agents Revue Medicale de Liege 51(1): 65-69
Hirsch, S.R.; Link, C.G.; Goldstein, J.M.; Arvanitis, L.A. 1996: ICi 204,636: a new atypical antipsychotic drug British Journal of Psychiatry. Suppl 29: 45-56